Skye Bioscience Inc.

📍 San Diego, United States🗓 Founded 2012👥 16 employees💰 Last funded Mar 2024
Skye Bioscience (Nasdaq: SKYE) is focused on unlocking the pharmaceutical potential of the endocannabinoid system, initially through modulation of the CB1 receptor, to treat diseases with inflammatory, fibrotic, and metabolic processes.
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
2012
Founded
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Skye Bioscience Inc.?
Skye Bioscience Inc. has 1 investor on record on gritt.io.
When did Skye Bioscience Inc. last raise funding?
The most recent investment in Skye Bioscience Inc. recorded on gritt.io was in March 2024.
When was Skye Bioscience Inc. founded?
Skye Bioscience Inc. was founded in 2012.
What industry is Skye Bioscience Inc. in?
Skye Bioscience Inc. operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Skye Bioscience Inc. based?
Skye Bioscience Inc. is headquartered in San Diego, United States.